OptimizeRx Corp
Close on Oct 19, 2026
- Market cap
- $164.19M
- P/E (TTM)
- 36.4
- Dividend yield
- –
Earnings
Next report expected Nov 5, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 12, 2026 | After market close | $20.50M | $-0.04 | $0.16 |
| Q1 FY2026 Ended Mar 31, 2026 | May 12, 2026 | After market close | $19.80M | $-0.03 | $0.14 |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 5, 2026 | After market close | $32.20M | $0.26 | $0.51 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 6, 2025 | After market close | $26.10M | $0.04 | $0.20 |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 7, 2025 | After market close | $29.20M | $0.08 | $0.24 |
| Q1 FY2025 Ended Mar 31, 2025 | May 12, 2025 | After market close | $21.90M | $-0.12 | $0.08 |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 12, 2025 | Before market open | $32.30M | $0.00 | $0.30 |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 13, 2024 | After market close | – | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 8, 2024 | After market close | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | Apr 2, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 11, 2024 | After market close | – | – | – |
Company guidance
Outlook given with results on Aug 12, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| adjusted EBITDAnon-GAAP | fiscal year 2026 | $21.00M to $25.00M | Maintained |
| revenue | fiscal year 2026 | $95.00M to $100.00M | Maintained |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements OptimizeRx filed with the SEC
OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.2 to Form 8-K
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
Material agreement · Agreement terminated · Results of operations · New financial obligation · EX-99.1 to Form 8-K
PRESS RELEASE, DATED APRIL 8, 2026
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
OptimizeRx Reports Strong Fourth Qu arter and Full Year 2025 Financial Results
Material agreement · Results of operations · Other events · EX-99.1 to Form 8-K
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
Results of operations · EX-99.1 to Form 8-K
OPTIMIZERX CORPORATION ANNOUNCES LEADERSHIP TEAM ADVANCEMENTS TO ACCELERATE STRATEGIC GROWTH
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED JUNE 24, 2025
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE OF OPTIMIZERX CORPORATION ISSUED ON APRIL 18, 2025
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, DATED MARCH 12, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED MARCH 10, 2025
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE, DATED DECEMBER 23, 2024
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE, DATED NOVEMBER 13, 2024
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED AUGUST 8, 2024
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED MAY 14, 2024
Results of operations · EX-99.1 to Form 8-K
Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED APRIL 16, 2024
Results of operations · EX-99.1 to Form 8-K
TRANSCRIPT OF CONFERENCE CALL, DATED MARCH 28, 2024
Material agreement · Results of operations · EX-99.1 to Form 8-K
Loss on disposal of business
Material agreement · Results of operations · EX-99.2 to Form 8-K
PRESS RELEASE, DATED MARCH 11, 2024
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED JANUARY 25, 2024
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE, DATED NOVEMBER 6, 2023
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE OF OPTIMIZERX DATED OCTOBER 25, 2023
Material agreement · Acquisition or disposition completed · Unregistered share sale · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE OF OPTIMIZERX DATED OCTOBER 12, 2023
Material agreement · Results of operations · New financial obligation · Unregistered share sale · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE, DATED AUGUST 14, 2023
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED MAY 10, 2023
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED MARCH 8, 2023
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED NOVEMBER 8, 2022
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED AUGUST 9, 2022 (CORRECTED)
Results of operations · EX-99.1 to Form 8-K/A
PRESS RELEASE, DATED AUGUST 9, 2022
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED MAY 4, 2022
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED FEBRUARY 24, 2022
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED FEBRUARY 15, 2022
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED DECEMBER 22, 2021
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
TRANSCRIPT OF OPTIMIZERX CORPORATION CONFERENCE CALL ON NOVEMBER 9, 2021
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED NOVEMBER 9, 2021
Results of operations · EX-99.1 to Form 8-K